Health Catalyst, Inc.
HCAT
$2.99
$0.072.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -5.45% | 1.65% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.45% | 1.65% | |||
| Cost of Revenue | -11.50% | 1.59% | |||
| Gross Profit | 1.20% | 1.71% | |||
| SG&A Expenses | -9.49% | -0.99% | |||
| Depreciation & Amortization | -0.55% | 2.95% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.10% | -0.66% | |||
| Operating Income | 34.38% | 14.14% | |||
| Income Before Tax | 45.75% | -73.83% | |||
| Income Tax Expenses | -49.38% | -62.33% | |||
| Earnings from Continuing Operations | 45.75% | -72.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 45.75% | -72.60% | |||
| EBIT | 34.38% | 14.14% | |||
| EBITDA | 188.98% | 52.47% | |||
| EPS Basic | 46.32% | -69.94% | |||
| Normalized Basic EPS | 21.11% | 10.10% | |||
| EPS Diluted | 46.32% | -69.94% | |||
| Normalized Diluted EPS | 21.11% | 10.10% | |||
| Average Basic Shares Outstanding | 1.08% | 1.57% | |||
| Average Diluted Shares Outstanding | 1.08% | 1.57% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||